… Medical College of Wisconsin in Milwaukee. LOTIS-7 Trial Design Emerging trials … Dana-Farber Cancer Institute in … trial (NCT03274492) evaluated a modified regimen of rituximab (Rituxan), cyclophosphamide … drug conjugate loncastuximab tesirine for the treatment …

… Changzheng Hospital of the Naval Medical University in China. How … #47;m2 per day and cyclophosphamide at 300 mg/m2 … primary end point in both trials. Secondary end points included … , respectively. The most common treatment-emergent adverse effects in the …

… trial or treatment with an investigational study drug, … topotecan; lurbinectedin; taxane; cyclophosphamide, doxorubicin, and vincristine … Agency for Medicines and Medical Devices (ClinicalTrials … National Cancer Institute. Small cell lung cancer treatment ( …

… trial in aphthous ulcers of Behçet's Disease, enabling the medical … Drug designation for the treatment of Behçet's Disease by the FDA … drugs (e.g., cyclosporine or cyclophosphamide). These drugs … clinical trials of therapeutics and vaccines, obtaining …

… phase 3 trial of its kidney transplant drug imlifidase—which … in previous anti-GBM trials, it did not show … plasma exchange (PLEX) combined with cyclophosphamide (CYC) and glucocorticoids. “ … name for the treatment is Idefirix.  The medication is also approved …

… access to life-saving treatment—particularly for patients from … Jimenez, associate professor of medicine in the Division of … based on post-transplant cyclophosphamide (PTCy). This approach … . The trial enrolled 268 adults with blood cancers who received …

… published in Therapeutic Advances in Medical Oncology.1 About two-thirds … (Rituxan; Genentech and Biogen) plus cyclophosphamide, doxorubicin, vincristine, and prednisone, the … response (CR),” they wrote. Subsequent treatments tend to be ineffective, they …

… His medical history included tuberculosis (status post treatment), gout … mofetil, azathioprine and cyclophosphamide, which are indicated … immunosuppression, patients can trial anti-TNF agents … recruiting trials, guidelines Clinical Guidance, Healio CME, FDA …

… only randomized controlled trial to date further … medical history (symptoms, comorbid conditions, smoking, and treatment), … third reviewer. Treatment Clinical treatment for IRF patients … drugs in dual or triple regimens. Traditional IM included cyclophosphamide …

… (rituximab [Rituxan] plus cyclophosphamide, doxorubicin, vincristine, and prednisone … Falchi, MD, a medical oncologist and hematologist and … at Memorial Sloan Kettering Cancer Center, in New … the study authors wrote. Treatment-emergent adverse effects (TEAES …